GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM4142
Query DataSets for GSM4142
Status
Public on Feb 22, 2003
Title
PGA-MLS-Dil-1bAv2-s1
Sample type
RNA
Source name
Murine Lung
Organism
Mus musculus
Extracted molecule
total RNA
Description
Two groups of 3 days old mice were treated with oil or retinoic acid. At day 4 one half of each group was treated with saline solution or dexametasone. Lungs were removed snap frozed for RNA extraction
Submission date
Feb 20, 2003
Last update date
Oct 01, 2019
Contact name
Eric P Hoffman
E-mail(s)
ericphoffman@gmail.com
Organization name
Binghamton University - SUNY
Department
Pharmaceutical Sciences
Street address
PO Box 6000
City
Binghamton
State/province
NY
ZIP/Postal code
13902
Country
USA
Platform ID
GPL81
Series (1)
GSE484
Alveoli septation inhibition and protection
Data table header descriptions
ID_REF
VALUE
Average Difference Intensity (See Affymetrix Literature)
ABS_CALL
Presence or Absence of gene transcript in sample
Data table
ID_REF
VALUE
ABS_CALL
AFFX-MurIL2_at
65.125534
A
AFFX-MurIL10_at
29.109837
A
AFFX-MurIL4_at
100.46096
A
AFFX-MurFAS_at
274.214752
A
AFFX-BioB-5_at
618.196045
M
AFFX-BioB-M_at
1097.413208
P
AFFX-BioB-3_at
481.285553
P
AFFX-BioC-5_at
2158.055176
P
AFFX-BioC-3_at
1354.277222
P
AFFX-BioDn-5_at
1684.233887
P
AFFX-BioDn-3_at
11985.107422
P
AFFX-CreX-5_at
18987.310547
P
AFFX-CreX-3_at
37964.957031
P
AFFX-DapX-5_at
33.30862
A
AFFX-DapX-M_at
139.311523
A
AFFX-DapX-3_at
23.72159
A
AFFX-LysX-5_at
18.528425
A
AFFX-LysX-M_at
185.04361
A
AFFX-LysX-3_at
55.567863
A
AFFX-PheX-5_at
159.714294
A
Total number of rows:
12488
Table truncated, full table size
279 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM4142.CEL.gz
2.9 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
